Rachel K. King's Net Worth
$1.42 Million
Who is Rachel K. King?
Rachel K. King has an estimated net worth of $1.42 Million. This is based on reported shares across multiple companies, which include NOVAVAX INC, and GLYCOMIMETICS INC.
SEC CIK
Rachel K. King's CIK is 0001589712
Past Insider Trading and Trends
2021 was Rachel K. King's most active year for acquiring shares with 7 total transactions. Rachel K. King's most active month to acquire stocks was the month of May. 2020 was Rachel K. King's most active year for disposing of shares, totalling 2 transactions. Rachel K. King's most active month to dispose stocks was the month of May. 2019 saw Rachel K. King paying a total of $232,332.88 for 535,759 shares, this is the most they've acquired in one year. In 2020 Rachel K. King cashed out on 214,997 shares for a total of $329,128.16, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NOVAVAX INC (NVAX) Snapshot price: $3.785
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +54.45% | 6.67K |
—
|
—
| 18.92K |
Jun 12
| |||
Form 4
| +44.60% | 3.1K |
—
|
—
| 10.05K |
Jun 10 - Jun 12
| |||
Form 4
| +11.20% | 700 |
—
|
—
| 6.95K |
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4/A
| +123.21% | 3.45K |
—
|
—
| 6.25K |
Jun 25
| |||
Form 4
| +246.43% | 6.9K |
—
|
—
| 9.7K |
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +33.33% | 700 |
$139.64 | $97,748.00 | 2.8K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
|
∞
| 86K |
$0.53 | $45,562.80 | 86K |
Mar 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GLYCOMIMETICS INC (GLYC) Snapshot price: $3.19
President, CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +0.65% | 3.33K |
$3.00 | $10,002.00 | 515.19K |
Mar 29
| |||
Form 4
| +0.83% | 4.24K |
$2.36 | $10,001.68 | 511.86K |
Dec 29
| |||
Form 4
| +1.33% | 6.67K |
$1.50 | $10,000.50 | 507.62K |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +27.03% | 96.25K |
—
|
—
| 452.31K |
Jan 20
| |||
Form 4
| +15.08% | 46.65K |
$2.52 | -$182,608.64 | 356.06K |
Scheduled
|
Dec 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
| +118.79% | 166.76K |
$1.12 | $186,770.08 | 307.14K |
Aug 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
| +42.66% | 50K |
$1.12 | $56,000.00 | 167.21K |
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
| +1,148.63% | 100K |
$1.12 | $112,000.00 | 108.71K |
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||